Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Anti-HER2-CAR-T Cells by Shanghai First Song Therapeutics for Gastric Cancer: Likelihood of Approval
Anti-HER2-CAR-T Cells is under clinical development by Shanghai First Song Therapeutics and currently in Phase I for Gastric Cancer. According...
Anti-HER2-CAR-T Cells by Shanghai First Song Therapeutics for Metastatic Breast Cancer: Likelihood of Approval
Anti-HER2-CAR-T Cells is under clinical development by Shanghai First Song Therapeutics and currently in Phase I for Metastatic Breast Cancer....
Anti-HER2-CAR-T Cells by Shanghai First Song Therapeutics for Metastatic Pancreatic Cancer: Likelihood of Approval
Anti-HER2-CAR-T Cells is under clinical development by Shanghai First Song Therapeutics and currently in Phase I for Metastatic Pancreatic Cancer....
Anti-HER2-CAR-T Cells by Shanghai First Song Therapeutics for Solid Tumor: Likelihood of Approval
Anti-HER2-CAR-T Cells is under clinical development by Shanghai First Song Therapeutics and currently in Phase I for Solid Tumor. According...
Anti-HER2-CAR-T Cells by Shanghai First Song Therapeutics for Metastatic Colorectal Cancer: Likelihood of Approval
Anti-HER2-CAR-T Cells is under clinical development by Shanghai First Song Therapeutics and currently in Phase I for Metastatic Colorectal Cancer....